Combination oral acetazolamide and intravenous furosemide on acute decompensated heart failure

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Mrs Inne Pratiwi Farissa

Dr. Kariadi Central Hospital, Semarang (Indonesia)

6 More presentations in this session

Presentation thumbnail

Discussant panel

Presentation thumbnail

Kidney function trajectories before and after heart failure hospitalization in heart failure with reduced ejection fraction: findings from clinical trials and real-world data

Professor N. Girerd (Nancy, FR)

Presentation thumbnail

Sodium chloride vs. glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure

Associate Professor J. Biegus (Wroclaw, PL)

Presentation thumbnail

Impact of a urinary-sodium driven algorithm to optimize natriuresis in patients with ADHF: the FASTR trial

Associate Professor K. Damman (Groningen, NL)

Presentation thumbnail

A multicenter, randomized, double-blind, placebo-controlled, parallel group study on the safety and efficacy of istaroxime for pre-cardiogenic shock

Associate Professor J. Biegus (Wroclaw, PL)

Access the full session

Session thumbnail

Late-breaking science in acute heart failure

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Presentation

Acetazolamide for patients with acute decompensated heart failure: a systematic review and meta-analysis of randomised controlled trials

Congress Presentation

The role of acetazolamide in enhancing diuresis in acute decompensated heart failure: insights from a real-world retrospective cohort study

Congress Presentation

Could combined diuretic therapy increase decongestion in patients with acute heart failure?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources